Legalize59765 laws
59765 laws
- § 379d–3. Streamlined hiring authority
- § 379d–3a. Hiring authority for scientific, technical, and professional personnel
- § 379d–3b. Strategic Workforce Plan and report
- § 379d–4. Reporting requirements
- § 379d–5. Guidance document regarding product promotion using the Internet
- § 379e. Listing and certification of color additives for foods, drugs, devices, and cosmetics
- § 379f. Recovery and retention of fees for freedom of information requests
- § 384b. Voluntary qualified importer program
- § 379g. Definitions
- § 379h. Authority to assess and use drug fees
- § 379h–1. Fees relating to advisory review of prescription-drug television advertising
- § 379h–2. Reauthorization; reporting requirements
- § 379i. Definitions
- § 379j. Authority to assess and use device fees
- § 379j–1. Reauthorization; reporting requirements
- § 379j–11. Definitions
- § 384c. Inspection of foreign food facilities
- § 379j–12. Authority to assess and use animal drug fees
- § 379j–13. Reauthorization; reporting requirements
- § 379j–21. Authority to assess and use generic new animal drug fees
- § 379j–22. Reauthorization; reporting requirements
- § 379j–31. Authority to collect and use fees
- § 379j–41. Definitions
- § 379j–42. Authority to assess and use human generic drug fees
- § 379j–43. Reauthorization; reporting requirements
- § 384d. Accreditation of third-party auditors
- § 379j–51. Definitions
- § 379j–52. Authority to assess and use biosimilar biological product fees
- § 379j–53. Reauthorization; reporting requirements
- § 379j–61. Definitions
- § 379j–62. Authority to assess and use outsourcing facility fees
- § 379j–71. Definitions
- § 379j–72. Authority to assess and use OTC monograph fees
- § 379j–73. Reauthorization; reporting requirements
- § 379k. Information system
- § 379k–1. Electronic format for submissions
- § 379l. Education
- § 379o. Environmental impact
- § 379r. National uniformity for nonprescription drugs
- § 379s. Preemption for labeling or packaging of cosmetics
- § 379v. Safety report disclaimers
- § 381. Imports and exports
- § 382. Exports of certain unapproved products
- § 383. Office of International Relations
- § 384. Importation of prescription drugs
- § 384a. Foreign supplier verification program
- § 384e. Recognition of foreign government inspections
- § 384f. Strengthening FDA and CBP coordination and capacity
- § 384g. Restricting entrance of illicit drugs
- § 387. Definitions